(Q34655133)

3 August 2017

1 reference

title

Management of hypercholesterolaemia in postmenopausal women. (English)

1 reference

3 August 2017

0 references

2

Kevin C Maki

1 reference

3 August 2017

Michael H Davidson

1

1 reference

3 August 2017

Sherry Katz Karp

series ordinal

3

1 reference

3 August 2017

Kate A Ingram

series ordinal

4

1 reference

3 August 2017

publication date

1 January 2002

1 reference

3 August 2017

1 reference

3 August 2017

volume

19

1 reference

3 August 2017

issue

3

1 reference

3 August 2017

page(s)

169-178

1 reference

https://scigraph.springernature.com/pub.10.2165/00002512-200219030-00002

3 August 2017

exact match

0 references

cites work

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

12 December 2020

Effect of pravastatin on cardiovascular events in women after myocardial infarction: the cholesterol and recurrent events (CARE) trial.

1 reference

12 December 2020

Sex differences in coronary heart disease. Why are women so superior? The 1995 Ancel Keys Lecture

1 reference

12 December 2020

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

1 reference

12 December 2020

Monotherapy with HMG-CoA reductase inhibitors and secondary prevention in coronary artery disease

1 reference

12 December 2020

Influence of age and menopause on serum lipids and lipoproteins in healthy women.

1 reference

12 December 2020

Reduction of Serum Cholesterol with Sitostanol-Ester Margarine in a Mildly Hypercholesterolemic Population

1 reference

12 December 2020

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

12 December 2020

Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS): efficacy and tolerability of long-term treatment with lovastatin in women

1 reference

12 December 2020

Long-term effects of consuming foods containing psyllium seed husk on serum lipids in subjects with hypercholesterolemia

1 reference

12 December 2020

Sex bias and underutilization of lipid-lowering therapy in patients with coronary artery disease at academic medical centers in the United States and Canada. Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial (PREVENT) Invest

1 reference

12 December 2020

How do we explain the clinical benefits of estrogen? From bedside to bench

1 reference

12 December 2020

Colesevelam hydrochloride: a novel bile acid-binding resin

1 reference

12 December 2020

Treatment patterns and distribution of low-density lipoprotein cholesterol levels in treatment-eligible United States adults

1 reference

12 December 2020

Effectiveness of atorvastatin for reducing low-density lipoprotein cholesterol to National Cholesterol Education Program treatment goals.

1 reference

12 December 2020

The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals

1 reference

12 December 2020

Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study

1 reference

12 December 2020

Adherence to National Cholesterol Education Program Treatment goals in postmenopausal women with heart disease. The Heart and Estrogen/Progestin Replacement Study (HERS). The HERS Research Group

1 reference

12 December 2020

Dense low density lipoproteins and coronary artery disease

1 reference

12 December 2020

A psyllium-enriched cereal for the treatment of hypercholesterolemia in children: a controlled, double-blind, crossover study

1 reference

12 December 2020

Consensus for the use of fibrates in the treatment of dyslipoproteinemia and coronary heart disease. Fibrate Consensus Group

1 reference

12 December 2020

Colesevelam hydrochloride (cholestagel): a new, potent bile acid sequestrant associated with a low incidence of gastrointestinal side effects

1 reference

12 December 2020

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

1 reference

12 December 2020

Cholesterol lowering with high-viscosity hydroxypropylmethylcellulose

1 reference

12 December 2020

Prevalence of high blood cholesterol among US adults. An update based on guidelines from the second report of the National Cholesterol Education Program Adult Treatment Panel.

1 reference

12 December 2020

The hypocholesterolemic effects of beta-glucan in oatmeal and oat bran. A dose-controlled study

1 reference

12 December 2020

Inadequate treatment with HMG-CoA reductase inhibitors by health care providers

1 reference

12 December 2020

Oral versus transdermal hormone replacement therapy

1 reference

12 December 2020

Achieving National Cholesterol Education Program goals for low-density lipoprotein cholesterol in cardiac patients: importance of diet, exercise, weight control, and drug therapy

1 reference

12 December 2020

Comparative efficacy and safety of micronized fenofibrate and simvastatin in patients with primary type IIa or IIb hyperlipidemia

1 reference

12 December 2020

Clinical profiles of plain versus sustained-release niacin (Niaspan) and the physiologic rationale for nighttime dosing

1 reference

12 December 2020

Extended-release niacin vs gemfibrozil for the treatment of low levels of high-density lipoprotein cholesterol. Niaspan-Gemfibrozil Study Group

1 reference

12 December 2020

The MRC/BHF Heart Protection Study: preliminary results.

1 reference

12 December 2020

Effect of niacin on atherosclerotic cardiovascular disease

1 reference

12 December 2020

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

1 reference

12 December 2020

The rule of 5 and the rule of 7 in lipid-lowering by statin drugs.

1 reference

12 December 2020

Long-term maintenance of a low-fat diet: durability of fat-related dietary habits in the Women's Health Trial

1 reference

12 December 2020

AHA/ACC scientific statement: consensus panel statement. Guide to preventive cardiology for women. American Heart Association/American College of Cardiology

1 reference

12 December 2020

Lipid responses to plant-sterol-enriched reduced-fat spreads incorporated into a National Cholesterol Education Program Step I diet

1 reference

12 December 2020

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

12 December 2020

Systematic review on the risk and benefit of different cholesterol-lowering interventions

1 reference

12 December 2020

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

1 reference

12 December 2020

Changes in LDL density across the menopausal transition

1 reference

12 December 2020

Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial

1 reference

12 December 2020

High-molecular-weight hydroxypropylmethylcellulose taken with or between meals is hypocholesterolemic in adult men.

1 reference

12 December 2020

Treatment of hyperlipidemia with combined niacin-statin regimens

1 reference

12 December 2020

Clofibrate and niacin in coronary heart disease

1 reference

12 December 2020

Drug therapy for hypercholesterolemia in patients with cardiovascular disease: factors limiting achievement of lipid goals

1 reference

12 December 2020

Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel

1 reference

12 December 2020

A comparison of estrogen replacement, pravastatin, and combined treatment for the management of hypercholesterolemia in postmenopausal women

1 reference

12 December 2020

Hormone replacement therapy and increased plasma concentration of C-reactive protein

1 reference

12 December 2020

Comparison of properties of four inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase

1 reference

12 December 2020

Does differing metabolism by cytochrome p450 have clinical importance?

1 reference

12 December 2020

Incremental reduction of serum total cholesterol and low-density lipoprotein cholesterol with the addition of plant stanol ester-containing spread to statin therapy

1 reference

12 December 2020

Comparison of effects on low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with rosuvastatin versus atorvastatin in patients with type IIa or IIb hypercholesterolemia

1 reference

12 December 2020

Oat products and lipid lowering. A meta-analysis

1 reference

12 December 2020

Cholesterol-lowering effects of psyllium intake adjunctive to diet therapy in men and women with hypercholesterolemia: meta-analysis of 8 controlled trials

1 reference

12 December 2020

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

1 reference

12 December 2020

Postmenopausal hormone replacement therapy, coronary heart disease and plasma lipoproteins.

1 reference

12 December 2020

Raloxifene lowers serum lipoprotein(A) in healthy postmenopausal women: a randomized, double-blind, placebo-controlled comparison with conjugated equine estrogens

1 reference

12 December 2020

Effects of estrogen replacement on the progression of coronary-artery atherosclerosis

1 reference

12 December 2020

Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group

1 reference

12 December 2020

Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause

1 reference

12 December 2020

Menopause and heart disease. A review

1 reference

12 December 2020

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

Estrogen and progestin compared with simvastatin for hypercholesterolemia in postmenopausal women.

1 reference

12 December 2020

Effect of micronized fenofibrate on plasma lipoprotein levels and hemostatic parameters of hypertriglyceridemic patients with low levels of high-density lipoprotein cholesterol in the fed and fasted state.

1 reference

12 December 2020

The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease

1 reference

12 December 2020

Lipid management: tools for getting to the goal

1 reference

12 December 2020

Effects of continuous estrogen and estrogen-progestin replacement regimens on cardiovascular risk markers in postmenopausal women

1 reference

12 December 2020

The effect of hormone replacement therapy alone and in combination with simvastatin on plasma lipids of hypercholesterolemic postmenopausal women with coronary artery disease.

1 reference

12 December 2020

Effect of micronized fenofibrate and losartan combination on uric acid metabolism in hypertensive patients with hyperuricemia

1 reference

12 December 2020

10.2165/00002512-200219030-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

3 August 2017

1024993756

0 references

1 reference